Assertio Therapeutics Inc (ASRT) is a drug manufacturers - specialty & generic company listed on US.
Latest reported ASRT revenue for 2024-12-31 was $125.0M. Net income was -$21.6M. Revenue was down 17.8% from 2023-12-31 to 2024-12-31. ASRT currently screens at market cap $151.5M.
Use this ASRT page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the ASRT quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the ASRT SEC filings page. Lician reads the product cache first so this HTML stays unique to Assertio Therapeutics Inc even when a live quote feed is slow.
Latest cached year on this hub. Full ASRT income, balance, and cash tables.